GEHC
GE Hltc Tech (GEHC)
NASDAQ
$63.46+$2.82 (+4.65%)
Price as of Jun 23, 2026 4:17 PM EDT
  • $27.6B
    Market Cap
  • -14.63%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
13.7B
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
8.9B
+8.11%
8.3B
-2.29%
8.5B
N/A
Gross Profit
8.2B
+0.52%
8.2B
+3.57%
7.9B
N/A
Sales and Marketing Expense
4.2B
-1.03%
4.3B
-0.30%
4.3B
N/A
Research and Development Expense
-1.3B
-3.89%
-1.3B
+8.80%
-1.2B
N/A
Depreciation and Amortization Expense
291.0M
-6.73%
312.0M
-13.81%
362.0M
N/A
Total Operating Expenses
5.5B
-1.70%
5.6B
+1.69%
5.5B
N/A
Operating Profit
2.8B
+38.64%
2.0B
+27.10%
1.6B
N/A
Interest Income
112.0M
+609.09%
-22.0M
-2,300.00%
1.0M
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
112.0M
+609.09%
-22.0M
-2,300.00%
1.0M
N/A
Total Nonoperating Income and Expense
157.0M
+185.45%
55.0M
-36.05%
86.0M
N/A
Income before Taxes
2.8B
+38.89%
2.0B
+27.10%
1.6B
N/A
Income Taxes
614.0M
+15.63%
531.0M
-28.53%
743.0M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
2.1B
+4.57%
2.0B
+27.10%
1.6B
N/A
Net Income from Continuing Operations Applicable to Common
2.1B
+4.57%
2.0B
+27.10%
1.6B
N/A
Basic EPS and Net Income
4.56
+4.35%
4.37
+43.28%
3.05
N/A
Diluted EPS and Net Income
4.55
+4.84%
4.34
+43.23%
3.03
N/A
Basic Weighted Average Shares
456.0M
0.00%
456.0M
+0.22%
455.0M
N/A
Diluted Weighted Average Shares
458.0M
-0.22%
459.0M
+0.22%
458.0M
N/A
Balance Sheet
Cash and Cash Equivalents
4.5B
+56.07%
2.9B
+15.44%
2.5B
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.5B
+56.07%
2.9B
+15.44%
2.5B
N/A
Total Current Assets
12.5B
+26.26%
9.9B
+295.09%
2.5B
N/A
Accumulated Depreciation
3.0B
-1.01%
3.1B
+0.52%
3.1B
N/A
Property and Plant and Equipment and Net
3.1B
+21.25%
2.5B
+18.94%
2.1B
N/A
Total Long-Term Assets
2.2B
+13.08%
1.9B
-22.00%
2.5B
N/A
Total Assets
36.9B
+11.54%
33.1B
+1.96%
32.5B
N/A
Income Taxes Payable
193.0M
+244.64%
56.0M
-17.65%
68.0M
N/A
Total Short-Term Debt
508.0M
-66.18%
1.5B
+49.30%
1.0B
N/A
Total Current Liabilities
9.1B
-4.69%
9.6B
+6.37%
9.0B
N/A
Total Long-Term Debt
9.5B
+27.47%
7.4B
-73.24%
27.8B
N/A
Total Long-Term Liabilities
2.1B
+14.76%
1.8B
-4.32%
1.9B
N/A
Total Liabilities
26.3B
+7.65%
24.4B
-2.81%
25.1B
N/A
Retained Earnings
5.3B
+61.89%
3.3B
+146.00%
1.3B
N/A
Total Stockholders Equity
10.4B
+22.89%
8.4B
+18.21%
7.1B
N/A
Total Shares Outstanding
458.8M
+0.35%
457.2M
+0.42%
455.3M
N/A
Cash Flow
Cash from Operating Activities
2.0B
+1.85%
2.0B
-7.14%
2.1B
N/A
Capital Expenditures
482.0M
+20.20%
401.0M
+3.62%
387.0M
N/A
Cash from Investing Activities
-1.0B
+14.55%
-914.0M
+63.80%
-558.0M
N/A
Dividends Paid
64.0M
+16.36%
55.0M
+34.15%
41.0M
N/A
Cash from Financing Activities
617.0M
+207.68%
-573.0M
+19.87%
-478.0M
N/A
Financials Ratio
Gross Margin
34.54%
N/A
N/A
N/A
N/A
N/A
Operating Margin
20.23%
N/A
N/A
N/A
N/A
N/A
Return on Assets
5.95%
-2.09%
6.08%
N/A
N/A
N/A
Return on Equity
22.14%
-13.40%
25.57%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.37
+32.48%
1.04
N/A
N/A
N/A
Cash Ratio
0.50
+63.77%
0.30
N/A
N/A
N/A
Debt-to-Equity Ratio
0.96
-9.06%
1.06
N/A
N/A
N/A
Debt-to-Assets Ratio
0.27
+0.18%
0.27
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow